A phase II prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (pLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B Meeting Abstract

  

Authors:	Fangusaro, J.; Onar-Thomas, A.; Young Poussaint, T.; Wu, S.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Packer, R. J.; Kilburn, L. B.; Goldman, S.; Pollack, I. F.; Jakacki, R. I.; Qaddoumi, I.; Fisher, P. G.; Dhall, G.; Baxter, P.; Kreissman, S. G.; Stewart, C. F.; Jones, D. T. W.; Pfister, S. M.; Vezina, G.; Stern, J. S.; Panigrahy, A.; Jones, B. V.; Patay, Z.; Tamrazi, B.; Jones, J. Y.; Haque, S. S.; Enterline, D. S.; Cha, S.; Fisher, M. J.; Doyle, A.; Smith, M.; Fouladi, M.; Dunkel, I. J.
Abstract Title:	A phase II prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (pLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B
Meeting Title:	5th Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research
Journal Title:	Neuro-Oncology
Volume:	21
Issue:	Suppl. 2
Meeting Dates:	2019 May 3-4
Meeting Location:	San Francisco, CA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2019-04-01
Start Page:	ii98
End Page:	ii99
Language:	English
ACCESSION:	WOS:000473243700146
DOI:	10.1093/neuonc/noz036.145
PROVIDER:	wos
Notes:	Meeting Abstract: LGG-02 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/150893